| Alternative Names: |
Actinomycin D, 3H-Phenoxazine-1,9-dicarboxamide, 2-amino-N,N-bis(hexadecahydro-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo- (7CI), Actinomycin C1 (6CI), 1H-Pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecine, cyclic peptide deriv., 3H-Phenoxazine, actinomycin D deriv., AD, Actactinomycin A IV, Actinomycin 7, Actinomycin AIV, Actinomycin I1, Actinomycin IV, Actinomycin X1, Actinomycindioic D acid, dilactone, C 1, Chounghwamycin B, Cosmegen, Dactinomycin, Dactinomycin D, Dilactone actinomycin D acid, Dilactone actinomycindioic D acid, Lyovac cosmegen, Meractinomycin, NCI C04682, NSC 3053, Oncostatin K, Stereoisomer of N,N-[(2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-diyl)bis[carbonylimino[2-(1-hydroxyethyl)-1-oxo-2,1-ethanediyl]imino[2-(1-methylethyl)-1-oxo-2,1-ethanediyl]-1,2-pyrrolidinediylcarbonyl(methylimino)(1-oxo-2,1-ethanediyl)]]bis[N-methyl-L-valine] di-xi-lactone |